Implications of Osteoblast-Osteoclast Interactions in the Management of Osteoporosis by Antiresorptive Agents Denosumab and Odanacatib
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Implications of Osteoblast-Osteoclast Interactions in the Management of Osteoporosis by Antiresorptive Agents Denosumab and Odanacatib
Authors
Keywords
Osteoclast, Osteoblast, Coupling, Odanacatib, Cathepsin K, Denosumab, RANKL
Journal
Current Osteoporosis Reports
Volume 12, Issue 1, Pages 98-106
Publisher
Springer Nature
Online
2014-01-29
DOI
10.1007/s11914-014-0196-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: A head-to-head comparison with alendronate
- (2013) Donald S. Williams et al. BONE
- The Bone Resorption Inhibitors Odanacatib and Alendronate Affect Post-Osteoclastic Events Differently in Ovariectomized Rabbits
- (2013) Pia Rosgaard Jensen et al. CALCIFIED TISSUE INTERNATIONAL
- Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity
- (2013) Yuriko Furuya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial
- (2013) Kim Brixen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation
- (2013) Sunao Takeshita et al. JOURNAL OF CLINICAL INVESTIGATION
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence
- (2013) Cristiano A. F. Zerbini et al. Therapeutic Advances in Musculoskeletal Disease
- Effects of Odanacatib on Bone Mineralization Density Distribution in Thoracic Spine and Femora of Ovariectomized Adult Rhesus Monkeys: A Quantitative Backscattered Electron Imaging Study
- (2012) Nadja Fratzl-Zelman et al. CALCIFIED TISSUE INTERNATIONAL
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study
- (2012) Bente Langdahl et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Spotlight on Denosumab in Postmenopausal Osteoporosis†
- (2011) Marit D. Moen et al. BIODRUGS
- The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking
- (2011) P. Leung et al. BONE
- Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
- (2011) Paul J. Kostenuik et al. BONE
- Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
- (2011) Michael S. Ominsky et al. BONE
- Discontinuation of odanacatib and other osteoporosis treatments: Here today and gone tomorrow?
- (2011) Douglas C Bauer JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys
- (2011) Patricia J Masarachia et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey
- (2011) Tara Cusick et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Suppression of bone formation by osteoclastic expression of semaphorin 4D
- (2011) Takako Negishi-Koga et al. NATURE MEDICINE
- Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys
- (2011) C. Jerome et al. OSTEOPOROSIS INTERNATIONAL
- Dissociation of Bone Resorption and Bone Formation in Adult Mice with a Non-Functional V-ATPase in Osteoclasts Leads to Increased Bone Strength
- (2011) Kim Henriksen et al. PLoS One
- Heritable sclerosing bone disorders
- (2010) Marie-Christine De Vernejoul et al. Annals of the New York Academy of Sciences
- Are Osteoclasts Needed for the Bone Anabolic Response to Parathyroid Hormone?
- (2010) Dominique D. Pierroz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
- (2010) Ian R Reid et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits
- (2010) Brenda L Pennypacker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect
- (2010) John A Eisman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Specialized roles for cysteine cathepsins in health and disease
- (2010) Jochen Reiser et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment with a Potent Cathepsin K Inhibitor Preserves Cortical and Trabecular Bone Mass in Ovariectomized Monkeys
- (2009) G. B. Stroup et al. CALCIFIED TISSUE INTERNATIONAL
- Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies
- (2009) S A Stoch et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- BMP-6 and mesenchymal stem cell differentiation
- (2009) Slobodan Vukicevic et al. CYTOKINE & GROWTH FACTOR REVIEWS
- TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
- (2009) Yi Tang et al. NATURE MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteoclasts secrete non-bone derived signals that induce bone formation
- (2008) Morten A. Karsdal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
- (2008) Jacques Yves Gauthier et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
- (2008) Paul D. Miller et al. BONE
- The anabolic action of intermittent PTH in combination with cathepsin K Inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice
- (2008) Hirotoshi Yamane et al. BONE
- Bone density, strength, and formation in adult cathepsin K (−/−) mice
- (2008) B. Pennypacker et al. BONE
- Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling
- (2008) Emma C Walker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Association Analysis of WNT10B With Bone Mass and Structure Among Individuals of African Ancestry
- (2008) Joseph M Zmuda et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*
- (2008) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*
- (2008) Paul J Kostenuik et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Antiresorptive Effects of a Single Dose of Zoledronate Persist for Two Years: A Randomized, Placebo-Controlled Trial in Osteopenic Postmenopausal Women
- (2008) Andrew Grey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
- (2008) L. Pederson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impaired growth plate function in bmp-6 null mice
- (2007) Mark J. Perry et al. BONE
- Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts
- (2007) Karen Fuller et al. BONE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now